3rd Quarter - Report
BUCHANAN INGERSOLL & ROONEY PC for AIM IMMUNOTECH INC.
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL P STRAZZELLA | — |
| JAMES C WILTRAUT | — |
Pharmacy PHA
Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL P STRAZZELLA | — |
| JAMES C WILTRAUT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.